Cervical cancer: is herpes simplex virus type II a cofactor?
In many ways, cervical cancer behaves as a sexually transmitted disease. The major risk factors are multiple sexual partners and early onset of sexual activity. Although high-risk types of human papillomaviruses (HPV) play an important role in the development of nearly all cases of cervical cancer, other sexually transmitted infectious agents may be cofactors. Herpes simplex virus type 2 (HSV-2) is transmitted primarily by sexual contact and therefore has been implicated as a risk factor. Several independent studies suggest that HSV-2 infections correlate with a higher than normal incidence of cervical cancer. In contrast, other epidemiological studies have concluded that infection with HSV-2 is not a major risk factor. Two separate transforming domains have been identified within the HSV-2 genome, but continued viral gene expression apparently is not necessary for neoplastic transformation. HSV infections lead to unscheduled cellular DNA synthesis, chromosomal amplifications, and mutations. These observations suggest that HSV-2 is not a typical DNA tumor virus. It is hypothesized that persistent or abortive infections induce permanent genetic alterations that interfere with differentiation of cervical epithelium and subsequently induce abnormal proliferation. Thus, HSV-2 may be a cofactor in some but not all cases of cervical cancer.
Jones
C
C
Department of Veterinary and Biomedical Sciences, University of Nebraska, Lincoln 68583, USA.
D005260:Female; D018258:Herpesvirus 2, Human / Q000235:genetics*; D006801:Humans; D009154:Mutation / Q000235:genetics; D027383:Papillomaviridae / Q000235:genetics*; D014170:Transformation, Genetic; D002583:Uterine Cervical Neoplasms / Q000821:virology*